FocusCELL THERAPY

Challenges for mesenchymal stromal cell therapies

See allHide authors and affiliations

Science Translational Medicine  20 Feb 2019:
Vol. 11, Issue 480, eaat2189
DOI: 10.1126/scitranslmed.aat2189

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Clinical trials of mesenchymal stromal cell therapies reveal a challenging heterogeneous landscape, including diverse therapeutic targets, patient categories, cell sources, and potential mechanisms of action.

View Full Text